Profile for Coherus BioSciences, Inc. (CHRS)
« Back to company indexCHRS Chatter Timeline
Stock Ticker for CHRS
Most Active Tweeters for CHRS
| User | Tweets |
|---|---|
| @SleekMoneycom | 8 |
| @TheMarketsDaily | 4 |
| @TickerReport | 4 |
| @bnbdailynews | 3 |
| @dailymailtimes | 3 |
Recent Tweets for CHRS
 |
@TheMarketsDaily Coherus BioSciences, Inc. $CHRS Stock Price Up 4.9% https://t.co/y4PTkxEzZi September 25th 2017, 9:09pm |
 |
@SleekMoneycom Coherus BioSciences $CHRS versus The Competition Head-To-Head Comparison https://t.co/qLK2JiwD6a September 25th 2017, 11:09am |
 |
@newswelldone $ABBV $CHRS: UBS Downgrades AbbVie; Here’s What Changed Analysts’ View: https://t.co/so85ZXJAc2 September 25th 2017, 9:09am |
 |
@dakotafinancial Somewhat Positive News Coverage Somewhat Unlikely to Affect Coherus BioSciences $CHRS Share Price https://t.co/KvDQuioeLG September 24th 2017, 12:09pm |
|
@SleekMoneycom Coherus BioSciences, Inc. $CHRS Given Outperform Rating at Cowen and Company https://t.co/YFs29HmDfD September 24th 2017, 6:09am |
 |
@MaisaCorp $CHRS S-3 Files for offering of upto 6.56 million shares of common stock by the selling stockholder? September 22nd 2017, 6:09pm |
 |
@odibro $CHRS S-3 shelf filed 6.5M shares September 22nd 2017, 5:09pm |
 |
@kshahi $CHRS https://t.co/TWzn1VpQbY September 22nd 2017, 5:09pm |
 |
@stocknewsdotcom $CHRS Files for 6,556,116 share common stock offering by selling stockholders https://t.co/Kn39pVuAst September 22nd 2017, 5:09pm |
 |
@4thQuarterCap Trimmed $CHRS -10% September 21st 2017, 7:09pm |
 |
@midetimes Comparing Coherus BioSciences $CHRS & Its Competitors https://t.co/b46K0v9sju September 20th 2017, 6:09pm |
 |
@ZolmaxNews $CHRS - Comparing Coherus BioSciences #CHRS & Its Competitors https://t.co/FBWAuei5I8 September 20th 2017, 6:09pm |
 |
@dailymailtimes Comparing Coherus BioSciences $CHRS & Its Competitors https://t.co/NIHYGUqQ8A September 20th 2017, 6:09pm |
 |
@DPolitical $CHRS - Comparing Coherus BioSciences #CHRS & Its Competitors https://t.co/5D2kYdLaxx September 20th 2017, 6:09pm |
|
@TheMarketsDaily Brokerages Set Coherus BioSciences, Inc. $CHRS Target Price at $34.78 https://t.co/EtoqlBtUUD September 20th 2017, 6:09pm |
|
@SleekMoneycom Brokerages Set Coherus BioSciences, Inc. $CHRS Target Price at $34.78 https://t.co/c04BIrcgYi September 20th 2017, 6:09pm |
 |
@dailypoliticaln Comparing Coherus BioSciences $CHRS & Its Competitors https://t.co/q2OeaOlByB September 20th 2017, 6:09pm |
 |
@WKRBNews Comparing Coherus BioSciences $CHRS & Its Competitors https://t.co/IQZe3LSUL2 September 20th 2017, 6:09pm |
|
@SleekMoneycom Coherus BioSciences, Inc. $CHRS Cut to Hold at Zacks Investment Research https://t.co/R7NjbiLdc7 September 19th 2017, 8:09pm |
|
@dailymailtimes Coherus BioSciences $CHRS – Research Analysts’ Weekly Ratings Updates https://t.co/h2aPDQQPEa September 18th 2017, 5:09pm |
|
@WKRBNews Coherus BioSciences $CHRS – Research Analysts’ Weekly Ratings Updates https://t.co/FIsK9yu1JV September 18th 2017, 5:09pm |
|
@midetimes Coherus BioSciences $CHRS – Research Analysts’ Weekly Ratings Updates https://t.co/WJL7hs0YBL September 18th 2017, 5:09pm |
 |
@intercooleronli Coherus BioSciences $CHRS – Research Analysts’ Weekly Ratings Updates https://t.co/GMJBh6LeVz September 18th 2017, 5:09pm |
|
@dailypoliticaln Coherus BioSciences $CHRS – Research Analysts’ Weekly Ratings Updates https://t.co/Zo2WjJvAOv September 18th 2017, 5:09pm |
 |
@CFinancialNews Coherus BioSciences $CHRS – Research Analysts’ Weekly Ratings Updates https://t.co/RC2GZZX4lh September 18th 2017, 5:09pm |
|
@SleekMoneycom Head-To-Head Contrast: Coherus BioSciences $CHRS vs. The Competition https://t.co/qLK2JiwD6a September 18th 2017, 11:09am |
 |
@SPNewsAnalysis Head-To-Head Contrast: Coherus BioSciences $CHRS vs. The Competition https://t.co/Sa0DX5oOHj September 18th 2017, 11:09am |
 |
@emq_news Coherus BioSciences, Inc. $CHRS Stake Decreased by Pacad Investment Ltd. https://t.co/Ng30CMODL4 September 18th 2017, 6:09am |
|
@CFinancialNews Coherus BioSciences, Inc. $CHRS Given Consensus Recommendation of “Buy” by Analysts https://t.co/1mCtMZEWfG September 17th 2017, 1:09pm |
|
@intercooleronli Coherus BioSciences, Inc. $CHRS Given Consensus Recommendation of “Buy” by Analysts https://t.co/9IxfrJsJnr September 17th 2017, 12:09pm |
 |
@chaffeybreeze Coherus BioSciences, Inc. $CHRS Sees Large Volume Increase https://t.co/m1J1Phj5j1 September 17th 2017, 9:09am |
 |
@IRAMarketReport Coherus BioSciences, Inc. $CHRS Sees Large Volume Increase https://t.co/jiW3qrdRrR September 17th 2017, 9:09am |
|
@chaffeybreeze Critical Review: Zafgen $ZFGN and Coherus BioSciences $CHRS https://t.co/heYnBaLvVA September 17th 2017, 5:09am |
|
@IRAMarketReport Critical Review: Zafgen $ZFGN and Coherus BioSciences $CHRS https://t.co/gpesEOaZgC September 17th 2017, 5:09am |
 |
@bnbdailynews Coherus BioSciences’ $CHRS Buy Rating Reiterated at Maxim Group https://t.co/LvxWRKOqUa September 16th 2017, 4:09pm |
|
@SleekMoneycom Coherus BioSciences, Inc. $CHRS Receives Outperform Rating from Cowen and Company https://t.co/YFs29HmDfD September 16th 2017, 2:09pm |
 |
@WatchlistN Coherus BioSciences, Inc. $CHRS Downgraded to Hold at Zacks Investment Research https://t.co/mpgICb8V58 September 16th 2017, 11:09am |
|
@TheMarketsDaily Axa Buys 44,976 Shares of Coherus BioSciences, Inc. $CHRS https://t.co/RO9LSKcZig September 16th 2017, 8:09am |
 |
@TickerReport Comparing Coherus BioSciences $CHRS and Its Rivals https://t.co/kPGSwmOW5z September 16th 2017, 3:09am |
|
@TickerReport Comparing Coherus BioSciences $CHRS and Its Rivals https://t.co/OMQJ1Bxy28 September 16th 2017, 3:09am |
|
@emq_news Comparing Coherus BioSciences $CHRS and Its Rivals https://t.co/KlLPNDw2IT September 16th 2017, 3:09am |
 |
@WeekHerald Coherus BioSciences, Inc. $CHRS Receives “Outperform” Rating from Cowen and Company https://t.co/YpoQS66p0i September 15th 2017, 9:09pm |
|
@TickerReport Coherus BioSciences, Inc. $CHRS Sees Large Volume Increase https://t.co/bwEKjIlh6s September 15th 2017, 9:09pm |
|
@emq_news Coherus BioSciences, Inc. $CHRS Sees Large Volume Increase https://t.co/H2zOG2LmqW September 15th 2017, 9:09pm |
|
@TickerReport Coherus BioSciences, Inc. $CHRS Sees Large Volume Increase https://t.co/0V9t6lMu1v September 15th 2017, 9:09pm |
|
@TheMarketsDaily Coherus BioSciences, Inc. $CHRS Downgraded by Zacks Investment Research https://t.co/fUTP7kjl97 September 15th 2017, 12:09pm |
 |
@fda_tracker $CHRS Phase 3 trial w/est Sep completion date NCT02486939: https://t.co/pGVkHSyWQj Trial Tracker: https://t.co/aR7q5oJwjn September 15th 2017, 9:09am |
|
@SleekMoneycom Maxim Group Reiterates “Buy” Rating for Coherus BioSciences, Inc. $CHRS https://t.co/GERD4edUGX September 15th 2017, 8:09am |
|
@intercooleronli Reviewing Coherus BioSciences $CHRS & Zafgen $ZFGN https://t.co/uwc2uA1kBq September 14th 2017, 12:09pm |
|
@CFinancialNews Reviewing Coherus BioSciences $CHRS & Zafgen $ZFGN https://t.co/Qg83LjKZRA September 14th 2017, 12:09pm |
Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.